Prime Minister Narendra Modi will visit Zydus Cadila’s plant close to Ahmedabad, Bharat Biotech’s office in Hyderabad and Serum Institute of India (SII) in Pune on Saturday to audit the Covid-19 antibody improvement work there.
The Prime Minister’s Office (PMO) tweeted on Friday about PM Modi’s visit today to 3 antibody plants. “Tomorrow, PM Narendra Modi will embark on a 3 city visit to personally review the vaccine development and manufacturing process. He will visit the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and Serum Institute of India in Pune,” the PMO composed on Twitter.
“As India enters a decisive phase of the fight against Covid-19, PM @narendramodis visit to these facilities and discussions with the scientists will help him get a first-hand perspective of the preparations, challenges and roadmap in India’s endeavour to vaccinate its citizens,” the PMO added.
Here are the Latest Updates from PM Modi’s three-city visit:
- PM Modi tweeted: “At the Bharat Biotech facility in Hyderabad, was briefed about their indigenous COVID-19 vaccine. Congratulated the scientists for their progress in the trials so far. Their team is closely working with ICMR to facilitate speedy progress.”
- PM Modi leaves Bharat Biotech office in Genome Valley in Hyderabad in the wake of taking a load of the indigenous Covid-19 antibody, Covaxin’s turn of events.
- Photographs from Modi’s Bharat Biotech visit
- The official record of the BJP, in a tweet, stated, “On his second stop during the review of COVID Vaccine development programs at 3 premier facilities in India, PM Shri @narendramodi visits Bharat Biotech in Hyderabad where scientists are working on a COVID-19 vaccine, COVAXIN.”
- Zydus Cadila on PM Narendra Modi visit
- PM Narendra Modi visits Bharat Biotech office in Hyderabad to survey the Covid immunization advancement.
- PM Modi lands in Hyderabad to visit the Bharat Biotech office to audit the Covid-19 immunization advancement.
- PM Modi will currently travel to Hyderabad to visit the Bharat Biotech office there.
- Subsequent to visiting Ahmedabad’s Zydus Biotech Park office, PM Modi took to Twitter saying, “Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila. I compliment the team behind this effort for their work. Government of India is actively working with them to support them in this journey.”
- PM Modi has closed his visit to Zydus Biotech Park close to Ahmedabad subsequent to assessing the advancement of Covid antibody applicant, ZyCOV-D. This visit was PM Modi’s first of his three-city visit to by and by survey the immunization improvement measure in India.
- PM Modi welcomes the group assembled outside Zydus Biotech Park close to Ahmedabad during his antibody survey visit on Saturday.
- The Prime Minister has shown up at the Zydus Biotech Park close to Ahmedabad to survey the advancement of Covid-19 immunization up-and-comer ZyCOV-D.
- PM Narendra Modi shows up at Gujarat’s Ahmedabad to visit the Zydus Biotech Park today to survey the Covid-19 antibody advancement at the office.
- PM Modi will visit pharma major Zydus Cadila’s plant close to Ahmedabad first to get data about the improvement of its Covid-19 antibody. According to reports, PM Modi is probably going to show up at the plant at around 9:30 am today.
- The plant is situated in the Changodar modern territory, more than 20 km from Ahmedabad. PM Modi will be at the plant for 60 minutes, according to reports.
- Medication producer Zydus Cadila has reported that the main period of clinical preliminary of its Covid antibody up-and-comer, ZyCoV-D, has been finished and it initiated the second period of clinical preliminaries in August.
- PM Modi will travel to Pune from Ahmedabad where the SII is based. The Serum Institute has joined forces with worldwide pharma goliath AstraZeneca and Oxford University for a Covid-19 antibody.
- PM Narendra Modi will at that point travel to Hyderabad and visit the Bharat BioTech office there, which is chipping away at Covaxin, pitched as India’s first indigenous immunization competitor.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Daily Pune journalist was involved in the writing and production of this article.
